BJDX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
2.3M
+21.2%
1.9M
+32.6%
1.5M
-9.6%
1.6M
-18.6%
2.0M
R&D
1.4M
+77.1%
811.8K
+38.5%
586.1K
-25.4%
785.6K
-11.7%
889.9K
SG&A
911.3K
-19.1%
1.1M
+28.7%
875.6K
+5.3%
831.3K
-24.1%
1.1M
Operating Income
-2349124
-21.2%
-1938831
-32.6%
-1461747
+9.6%
-1616947
+18.6%
-1985361
EBITDA
-2320931
-21.4%
-1911068
-33.2%
-1434332
+10.7%
-1606323
+18.4%
-1967619
Net Income
-2324013
-21.1%
-1919241
-34.2%
-1429812
+10.5%
-1597632
+18.3%
-1956604
EPS (Basic)
$-1.12
+42.6%
$-1.95
$-4.04
+28.4%
$-5.64
EPS (Diluted)
$-1.12
+42.6%
$-1.95
$-4.04
+28.4%
$-5.64
Shares (Diluted)
2.1M
+111.2%
984.7K
393.6K
+13.5%
346.8K
Bluejay Diagnostics (BJDX) — Financials